The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones

Turkish Journal of Gastroenterology

Volumn 14, Issue 2, 2003, Pages 91-96

  Tuncer, Ilyas ^a   Harman, Mustafa ^a   Mercan, Ridvan ^a   Öztürk, Mustafa ^a   Arslan, Ismail ^a   Meral, Cezmi ^a   Türkdoǧan, M Kur̈şat ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Aspirin; Gallstone dissolution; Ursodeoxycholic acid

Indexed keywords

ACETYLSALICYLIC ACID; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG SOLUBILITY; ECHOGRAPHY; FEMALE; GALLSTONE; GALLSTONE DISSOLUTION; GASTROINTESTINAL SYMPTOM; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHOLAGOGUES AND CHOLERETICS; CHOLECYSTOLITHIASIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; URSODEOXYCHOLIC ACID;

EID: 0042527527     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987; 7: 913-7.
2. Johnston DE, Kaplan M M. Pathogenesis and treatment of gallstones. N Engl J Med 1999; 328: 412-21.
3. Sterling RK, Shiffman ML. Nonsteroidal anti inflammatory drugs and gallstone disease: will an aspirin a day keep the gallstones a way? Am J Gastroenterol 1998; 93: 1405-7.
4. Bateson MC. Fortnightly review: Gallbladder disease. BMJ 1999; 318: 1745-8.
5. Apstein MD. Gallstone. In: Brandt LJ (ed). Clinical practice of gastroenterology. Philadelphia: Churchill-Livingstone, 1999: 1035-44.
6. Rubin RA, Kowalski TE, Khandelwal M, Malet PF. Ursodiol for hepatobiliary disorders. Ann Intern Med 1994; 121: 207-18.
7. Tsumita R, Sugiura N, Abe A, et al. Long-term evaluation of extracorporeal shock-wave lithotripsy for cholesterol gallstones. J Gastroenterol Hepatol 2001; 16: 93-9.
8. Das A, Baijal SS, Saraswat VA. Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double-blind, placebo-controlled trial of two dosage schedules. Dig Dis Sci 1995; 40: 1782-5.
9. Adamek HE, Buttmann A, Weber J, Riemann JF. Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy? Scand J Gastroenterol 1994; 29: 355-9.
10. Smith BF. Gallbladder mucin as a pronucleating agent for cholesterol monohydrate crystals in bile. Hepatology 1990; 12: 183-6.
11. th edit. Philadelpihia: Saunders, 2002; 1107-15.
12. Angelico M. The medical therapy of cholelithiasis. Critical reflections. Ann Ital Chir 1998; 69: 709-11.
13. Hood KA, Ruppin DC, Dowling RH. Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial. Gut 1993; 34: 1277-88.
14. Hirota I, Chijiiwa K, Noshiro H. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile. Gastroenterology 1992; 102: 1668-74.
15. Tokyo Cooperative Gallstone Study Group. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. Gastroenterology 1980; 78: 542-8.
16. May GR, Sutherland LR, Shaffer EA. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther 1993; 7: 139-48.
17. Dowling RH. Cholelithiasis: medical treatment. Clin Gastroenterol 1983; 12: 125-8.
18. Jazrawi RP, Pigozzi MG, Galatola G, et al. Optimum bile acid treatment for rapid gall stone dissolution. Gut 1992; 33: 381-6.
19. Schoenfield LJ, Marks JW. Oral and contact dissolution of gallstones. Am J Surg 1993; 165: 427-30.
20. Bazzoli F, Festi D, Mazzella G, et al. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids. Am J Gastroenterol 1995; 90: 978-81.
21. Lee SP, Carey MC, LaMont JT. Aspirin prevention of cholesterol gallstone formation in dogs. Science 1981; 211: 1429-31.
22. Vega KJ, Johnston DE. Exercise and the gallbladder. N Engl J Med 1999; 341: 836-7.
23. Heller FR. Sludge, gallstones and aspirin. Acta Gastroenterol Belg 1990; 53: 16-21.
24. Li YF, Russell DH, Myers SI, et al. Gallbladder contractility in aspirin- and cholesterol-fed prairie dogs. Gastroenterology 1994; 106: 1662-7.
25. Sahlin A, Ahlberg J, Einarsson K, et al. The effect of aspirin on gallbladder epithelium and bile composition in patients with gallstones. Eur J Gastroenterol Hepatol 1992; 4: 1019-24.
26. Cohen BI, Mosbach EH, Ayyad N, Yoshii M, McSherry CK. Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. Gastroenterology 1991; 101: 1109-16.
27. Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988; 319: 1567-72.
28. Pazzi P, Scagliarini R, Sighinolfi D, Govoni M, La Corte R, Gullini S. Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study Am J Gastroenterol 1998; 93: 1420-4.
29. Podda M, Zuin M, Dioguardi ML, et al. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation. Hepatology 1982; 2: 334-9.
30. Zuin M, Petroni ML, Grandinetti G, et al. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones. Scand J Gastroenterol 1991; 26: 257-62.
31. Petroni ML, Jazrawi RP, Pazzi P, et al. Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: A randomized multicentre trial. The British-Italian Gallstone Study group. Aliment Pharmacol Ther 2001; 15: 123-31.
32. Tazuma S, Kajiyama G, Mizuno T, et al. Combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than ursodeoxycholic monotherapy. J Clin Gastroenterol 1998; 26: 287-91.